Clinical trials have an impact on the environment, and novel approaches may help researchers reshape their activities toward a greater sustainability
A study proposes a model that is able to learn broad aspects of cancer–immune interactions from early phase trial data
ESMO is at the forefront of digital oncology, with some initiatives that support oncologists navigating the emerging opportunities in the field of real-world data research
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.